Pharmacokinetic and pharmacodynamic considerations for NMDA-receptor antagonist ketamine in the treatment of chronic neuropathic pain: an update of the most recent literature

Author(s):
Kamp, J.; Velzen, M. van (0000-0002-0289-6432); Olofsen, E.; Boon, M.; Dahan, A. (0000-0003-3161-3945); Niesters, M.
Published
2019
Publication type
Article / Letter to editor
Chronic neuropathic pain managementketaminehydroxynorketamineNMDA receptor antagonistpain
Date issued
2019-11-15
Language
English
Is part of
Expert Opinion on Drug Metabolism and Toxicology
hdl
1887/120886
doi
10.1080/17425255.2019.1689958